Prescription of Anti-Spike Monoclonal Antibodies in COVID-19 Patients with Resistant SARS-CoV-2 Variants in Italy

Anti-Spike monoclonal antibodies have been considered a promising approach to COVID-19 therapy. Unfortunately, the advent of resistant lineages jeopardized their effectiveness and prompted limitations in their clinical use. Change in the dominant variant can be fast to such an extent that, in the ab...

Descripción completa

Detalles Bibliográficos
Autores principales: Focosi, Daniele, Tuccori, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331784/
https://www.ncbi.nlm.nih.gov/pubmed/35894046
http://dx.doi.org/10.3390/pathogens11080823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331784/
https://www.ncbi.nlm.nih.gov/pubmed/35894046
http://dx.doi.org/10.3390/pathogens11080823

Ejemplares similares